The Global Microwave Ablation Market, mainly driven by increasing aging population with high risk of chronic diseases and increasing procedures through minimal invasive surgery was valued at $120 million in 2013 and is expected to reach $201 million by 2018.
Microwave thermotherapy is the technology employed in Microwave Ablation. This technique has potential in the treatment of cancers in primary and secondary stage for liver, lung, renal, adrenal and bone metastases.
Older population is on the rise in the mature markets such as Japan, U.S. and in the Western European countries. Currently, one quarter of the Japanese population is aged 65 and older. Currently, in the U.S., 40 million people are aged 65 and above and is expected that, by 2050 this number will rise to 89 million. The diseases such as cancer, cardiovascular disorders, gynecological, and orthopedic problems are on the rise. As the number of patient population will increase it will lead to increase in the procedural volume of minimally invasive surgeries, ultimately giving rise to increased demand for microwave ablation devices.
Emerging markets such as India, China, and Brazil have undergone significant economic development over the past decade. This development has also led to an increase in healthcare availability in these countries. Also, as these countries have relatively modest GDP per capita levels and highly variable healthcare systems, the need for inexpensive ablation devices is emerging as an important factor. It has provided an opportunity for microwave ablation devices companies, to have an established and growing market in these countries. European market is challenging, as it is a heterogeneous region in terms of regulatory and reimbursement approaches, with every country having its own unique characteristics. Aging Japanese population, which is at a higher risk of developing chronic diseases such as cancer and cardiac disorders, will ultimately lead to growth in procedure volume in the future.
The report also provides an extensive competitive landscaping of companies operating in microwave ablation market. Currently there are very few players in microwave ablation market, major players being Synapse Medical and Microsilus Medical (U.K.), recently entered into a strategic partnership with Angiodynamics (U.S).
Segment and country specific Company shares, News & Deals, M&A, segment specific pipeline products, product approvals and product recalls of the major companies have been detailed.
The market data enables you to customize the MMM assessments that meet your company’s specific needs. Customize to get comprehensive industry standard and deep dive analysis of the following parameters:
- Usage pattern (in-depth trend analysis) of products (Segment wise)
- Product Matrix which gives a detailed comparison of product portfolio of each company mapped at country and sub segment level
- End-user adoption rate analysis of the products (Segment wise and Country wise)
- Comprehensive coverage of Product approvals, Pipeline products and Product recalls
- Country specific Prevalence of cancer and cardiovascular disorders
- Country specific Patient pool of cancer and cardiovascular disorders
- Disease progression (Pattern analysis)
Surgeons/Physicians Perception analysis
- Fast turn-around analysis of Surgeons response to market events and trends
- Surgeons opinion about products from different companies
- Surgeons qualitative inputs on epidemiology date
Brand/Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connect tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (Detractor/Neutral/Familiar)
1.1 Analyst Insights
1.2 Market Definitions
1.3 Market Segmentation & Aspects Covered
1.4 Research Methodology
2 Executive Summary
3 Market Overview
4 By Products
5 By Geographies
5.1 North America
5.4 Rest of World
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
Americas Microwave Ablation
The American Microwave Ablation Market was pegged at $75 million in 2013 and expected to be $133 million by 2018. Currently there are very few players in microwave ablation market, major players being Synapse Medical, Microsilus Medical (U.K.) which recently entered into a strategic partnership with Angiodynamics (U.S).
Asia-Pacific Microwave Ablation
The Asia-Pacific Microwave Ablation Market was pegged at $15 million in 2013 and expected to be $31 million by 2018. Currently there are very few players in the Asia-Pacific Microwave Ablation market, major players being Synapse Medical, Microsilus Medical (U.K.) which recently entered into a strategic partnership with Angiodynamics (U.S).
European Microwave Ablation
The European Microwave Ablation Market was pegged at $27 million in 2013 and expected to be $45 million by 2018. Currently there are very few players in European Microwave Ablation market, major players being Synapse Medical, Microsilus Medical (U.K.) which recently entered into a strategic partnership with Angiodynamics (U.S).